Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2000

View Archived Issues

Phase III efficacy results reported for nalmefene in stroke

NIH awards phase I SBIR grant to Avanir for combination herpes therapy

InterMune Pharmaceuticals commences Actimmune trial in MDR-TB

Scotia licenses rights to Techniclone's VTA technology for use in PDT

SciClone begins marketing and distribution of Zadaxin in Mexico

Beta LT meets safety goals early in clinical trials

Initial trials demonstrate promise of PRO-542 HIV inhibitor

Tourette Syndrome symptoms improve with mecamylamine therapy

Human adenovirus linked to obesity in animals

First use of gene transfer to treat human neurodegenerative disease reported

Ampligen to be considered for orphan drug status in the E.U.

Licensing opportunity from NIH: leukocyte-based inhibition of viral replication

Oxcarbazepine shown to be beneficial in treating refractory partial epilepsy

FDA approves Rescula for treatment of glaucoma

Reminyl receives FDA approvable letter

Pfizer discontinues phase III trials of prinomastat in advanced cancers

PTSD indication sought for Paxil in Canada

Cell Pathways completes phase Ib trial of CP-461

New compounds under development at AstraZeneca for treatment of thrombosis

New compounds interacting with chemokine receptors under study at DuPont

New series of cyclic pyrazine derivatives useful for diabetes

New benzene derivatives useful for pulmonary thrombosis

New TNF inhibitors under development at Daiichi

Novel compounds under study at Melacure Therapeutics for treatment of eating disorders

New PDE5 inhibitors under study at Fujisawa useful for diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...